IBDEI2W1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46068,1,3,0)
 ;;=3^Vitreous Degeneration (PVD),Bilateral
 ;;^UTILITY(U,$J,358.3,46068,1,4,0)
 ;;=4^H43.813
 ;;^UTILITY(U,$J,358.3,46068,2)
 ;;=^5005955
 ;;^UTILITY(U,$J,358.3,46069,0)
 ;;=H43.812^^176^2297^2
 ;;^UTILITY(U,$J,358.3,46069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46069,1,3,0)
 ;;=3^Vitreous Degeneration (PVD),Left Eye
 ;;^UTILITY(U,$J,358.3,46069,1,4,0)
 ;;=4^H43.812
 ;;^UTILITY(U,$J,358.3,46069,2)
 ;;=^5005954
 ;;^UTILITY(U,$J,358.3,46070,0)
 ;;=H43.811^^176^2297^1
 ;;^UTILITY(U,$J,358.3,46070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46070,1,3,0)
 ;;=3^Vitreous Degeneration (PVD),Right Eye
 ;;^UTILITY(U,$J,358.3,46070,1,4,0)
 ;;=4^H43.811
 ;;^UTILITY(U,$J,358.3,46070,2)
 ;;=^5005953
 ;;^UTILITY(U,$J,358.3,46071,0)
 ;;=H43.13^^176^2297^9
 ;;^UTILITY(U,$J,358.3,46071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46071,1,3,0)
 ;;=3^Vitreous Hemorrhage,Bilateral
 ;;^UTILITY(U,$J,358.3,46071,1,4,0)
 ;;=4^H43.13
 ;;^UTILITY(U,$J,358.3,46071,2)
 ;;=^5005940
 ;;^UTILITY(U,$J,358.3,46072,0)
 ;;=H43.821^^176^2297^10
 ;;^UTILITY(U,$J,358.3,46072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46072,1,3,0)
 ;;=3^Vitreomacular Adhesion,Right Eye
 ;;^UTILITY(U,$J,358.3,46072,1,4,0)
 ;;=4^H43.821
 ;;^UTILITY(U,$J,358.3,46072,2)
 ;;=^5005957
 ;;^UTILITY(U,$J,358.3,46073,0)
 ;;=H43.822^^176^2297^11
 ;;^UTILITY(U,$J,358.3,46073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46073,1,3,0)
 ;;=3^Vitreomacular Adhesion,Left Eye
 ;;^UTILITY(U,$J,358.3,46073,1,4,0)
 ;;=4^H43.822
 ;;^UTILITY(U,$J,358.3,46073,2)
 ;;=^5005958
 ;;^UTILITY(U,$J,358.3,46074,0)
 ;;=H43.823^^176^2297^12
 ;;^UTILITY(U,$J,358.3,46074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46074,1,3,0)
 ;;=3^Vitreomacular Adhesion,Bilateral
 ;;^UTILITY(U,$J,358.3,46074,1,4,0)
 ;;=4^H43.823
 ;;^UTILITY(U,$J,358.3,46074,2)
 ;;=^5005959
 ;;^UTILITY(U,$J,358.3,46075,0)
 ;;=H43.391^^176^2297^15
 ;;^UTILITY(U,$J,358.3,46075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46075,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,46075,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,46075,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,46076,0)
 ;;=H43.392^^176^2297^16
 ;;^UTILITY(U,$J,358.3,46076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46076,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,46076,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,46076,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,46077,0)
 ;;=S05.31XA^^176^2298^1
 ;;^UTILITY(U,$J,358.3,46077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46077,1,3,0)
 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,46077,1,4,0)
 ;;=4^S05.31XA
 ;;^UTILITY(U,$J,358.3,46077,2)
 ;;=^5020606
 ;;^UTILITY(U,$J,358.3,46078,0)
 ;;=S05.32XA^^176^2298^2
 ;;^UTILITY(U,$J,358.3,46078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46078,1,3,0)
 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,46078,1,4,0)
 ;;=4^S05.32XA
 ;;^UTILITY(U,$J,358.3,46078,2)
 ;;=^5020609
 ;;^UTILITY(U,$J,358.3,46079,0)
 ;;=S01.121A^^176^2298^3
 ;;^UTILITY(U,$J,358.3,46079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46079,1,3,0)
 ;;=3^Laceration w/ FB,Right Eyelid,Init Encntr
 ;;^UTILITY(U,$J,358.3,46079,1,4,0)
 ;;=4^S01.121A
 ;;^UTILITY(U,$J,358.3,46079,2)
 ;;=^5020066
